Back to search
46 Three year study of adefovir dipivoxil (ADV) demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B (CHB) patients in a long term safety and efficacy study (LTSES)
Data up to Jan 2025
Published2004
Citations37
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...